These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34854369)

  • 1. Jatamansinol from
    Anupama KP; Shilpa O; Antony A; Gurushankara HP
    J Biomol Struct Dyn; 2023 Jan; 41(1):200-220. PubMed ID: 34854369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jatamansinol from Nardostachys jatamansi Ameliorates Tau-Induced Neurotoxicity in Drosophila Alzheimer's Disease Model.
    Anupama KP; Antony A; Shilpa O; Raghu SV; Gurushankara HP
    Mol Neurobiol; 2022 Oct; 59(10):6091-6106. PubMed ID: 35864434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jatamansinol from Nardostachys jatamansi (D.Don) DC. Protects Aβ
    Anupama KP; Shilpa O; Antony A; Raghu SV; Gurushankara HP
    Neurotoxicology; 2022 May; 90():62-78. PubMed ID: 35247505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary metabolite profiling, cytotoxicity, anti-inflammatory potential and in vitro inhibitory activities of Nardostachys jatamansi on key enzymes linked to hyperglycemia, hypertension and cognitive disorders.
    Bose B; Tripathy D; Chatterjee A; Tandon P; Kumaria S
    Phytomedicine; 2019 Mar; 55():58-69. PubMed ID: 30668444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
    Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
    Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nardostachys jatamansi Ethanol Extract Ameliorates Aβ42 Cytotoxicity.
    Liu QF; Jeon Y; Sung YW; Lee JH; Jeong H; Kim YM; Yun HS; Chin YW; Jeon S; Cho KS; Koo BS
    Biol Pharm Bull; 2018 Apr; 41(4):470-477. PubMed ID: 29398668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
    Gao H; Jiang Y; Zhan J; Sun Y
    Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico screening of glycogen synthase kinase-3β targeted ligands against acetylcholinesterase and its probable relevance to Alzheimer's disease.
    Jabir NR; Shakil S; Tabrez S; Khan MS; Rehman MT; Ahmed BA
    J Biomol Struct Dyn; 2021 Sep; 39(14):5083-5092. PubMed ID: 32588759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease.
    Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S
    Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailored Modeling of Rivastigmine Derivatives as Dual Acetylcholinesterase and Butyrylcholinesterase Inhibitors for Alzheimer's Disease Treatment.
    Adeowo FY; Oyetunji TP; Ejalonibu MA; Ndagi U; Kumalo HM; Lawal MM
    Chem Biodivers; 2021 Nov; 18(11):e2100361. PubMed ID: 34547176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tea polyphenols as multi-target therapeutics for Alzheimer's disease: An in silico study.
    Mazumder MK; Choudhury S
    Med Hypotheses; 2019 Apr; 125():94-99. PubMed ID: 30902161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
    Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
    Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
    Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach.
    Ambure P; Bhat J; Puzyn T; Roy K
    J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Search for new multi-target compounds against Alzheimer's disease among histamine H
    Bajda M; Łażewska D; Godyń J; Zaręba P; Kuder K; Hagenow S; Łątka K; Stawarska E; Stark H; Kieć-Kononowicz K; Malawska B
    Eur J Med Chem; 2020 Jan; 185():111785. PubMed ID: 31669851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer's disease.
    Gurjar AS; Darekar MN; Yeong KY; Ooi L
    Bioorg Med Chem; 2018 May; 26(8):1511-1522. PubMed ID: 29429576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A System Pharmacology Study for Deciphering Anti Depression Activity of Nardostachys jatamansi.
    Jalali S; Zarrinhaghighi A; Sadraei S; Ghasemi Y; Sakhteman A; Faridi P
    Curr Drug Metab; 2018; 19(5):469-476. PubMed ID: 29512454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
    Kumar S; Chowdhury S; Kumar S
    BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of Nrf2/Keap1/ARE in Alzheimer's Disease by Plant Secondary Metabolites: A Mechanistic Review.
    Fakhri S; Pesce M; Patruno A; Moradi SZ; Iranpanah A; Farzaei MH; Sobarzo-Sánchez E
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33114450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Screening of Traditional Medicinal Plants for Neuroprotective Activity against Aβ42 Cytotoxicity by Using Drosophila Models of Alzheimer's Disease.
    Liu QF; Lee JH; Kim YM; Lee S; Hong YK; Hwang S; Oh Y; Lee K; Yun HS; Lee IS; Jeon S; Chin YW; Koo BS; Cho KS
    Biol Pharm Bull; 2015; 38(12):1891-901. PubMed ID: 26458335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.